Related Experiment Video
Updated: Jun 10, 2026
09:03
Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
Using ligand-based virtual screening to allosterically stabilize the activated state of a GPCR
Christina M Taylor1, Nicole B Rockweiler, Cassie Liu
1Department of Biochemistry and Molecular Biophysics, Washington University, St. Louis, MO 63110, USA.
Chemical Biology & Drug Design
|July 28, 2010
Summary
Researchers identified novel small molecules that stabilize the activated state of rhodopsin, a G-protein coupled receptor. These allosteric ligands show promise for future crystallographic studies of activated receptors.
Area of Science:
- Biochemistry
- Structural Biology
- Pharmacology
Background:
- G-protein coupled receptors (GPCRs) are crucial in biological processes, but stabilizing their active conformation for structural analysis remains challenging.
- Previous work stabilized rhodopsin's active state using a tetrazole peptidomimetic, providing a basis for further investigation.
- Stabilizing GPCRs with small molecules binding to intracellular loops offers a novel strategy for structural studies.
Purpose of the Study:
- To discover novel small molecule scaffolds that can stabilize the active conformation of rhodopsin.
- To identify allosteric ligands that stabilize the MII state of rhodopsin without inhibiting transducin binding.
Main Methods:
- Developed a pharmacophore model from a previously designed tetrazole tetrapeptide.
- Performed ligand-based virtual screening of Maybridge Hitfinder and National Cancer Institute diversity libraries.
- Tested identified compounds for their ability to stabilize rhodopsin's MII state and assessed their effect on transducin binding.
Main Results:
- Virtual screening of the Maybridge library yielded 47 potential compounds; the NCI library yielded no hits.
- Three compounds from the Maybridge library were confirmed to stabilize the MII state of rhodopsin.
- These identified compounds act as allosteric ligands, not interfering with transducin binding.
Conclusions:
- Novel allosteric ligands capable of stabilizing rhodopsin's active conformation were identified.
- These compounds represent promising tools for future crystallographic studies aimed at capturing GPCRs in their activated states.
- The strategy of using small molecules to stabilize intracellular loops offers a viable approach for GPCR structural biology.
More Related Videos
Related Concept Videos
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:30Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...
01:22Activation and Inactivation of G Proteins
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...